{"id":1112953,"title":"DSEN Abstract: How safe is intravitreal bevacizumab to treat common causes of blindness? Emerging real-world data - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-28","captureTimestamp":"2026-02-28T18:58:05.617000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52247.html?wbdisable=false","snippet":"DSEN Abstract How safe is intravitreal bevacizumab to treat common causes of blindness? Emerging real-world data This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: Sasha Bernatsky and the CAN-AIM research…","rawSnapshotUrl":"/api/snapshots/raw/1112953","browseUrl":"https://replay.healtharchive.ca/job-8/20260228185805/https://cihr-irsc.gc.ca/e/52247.html?wbdisable=false#ha_snapshot=1112953","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}